Search

everythinglearnresearchcommunity

for

Search:↓

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

COVID-19 doesn't make alopecia areata worse.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Children's hair loss has many causes and requires careful diagnosis and personalized treatment, including emotional support.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.